OCI Global (Euronext: OCI), (“OCI,” the “Company”) announces today that it will pay a USD 700 million distribution (USD 3.31 per share) on 5 September 2025 through a mix of capital repayment and extraordinary cash dividend. This distribution is pursuant to the resolutions adopted at OCI's annual general meeting on 21 May and will follow […]
(NASDAQ:CERT), RADNOR, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) — Certara, Inc., a global leader in biosimulation, today announced that the European Medicines Agency (EMA) has formally qualified the Simcyp(R) Simulator for use in regulatory submissions across the EU. Certara is the first company to receive EMA qualification for a PBPK modeling platform, and Simcyp is
HAMPSHIRE, United Kingdom, Aug. 04, 2025 (GLOBE NEWSWIRE) — A new study from Juniper Research, the foremost experts in telecommunications and connectivity markets, has found operator revenue from network Application Programming Interfaces (APIs) globally will exceed $8 billion by 2030. This is a substantial increase from the $284 million operators are forecasted to generate in
Network API Revenue to Exceed $8 Billion by 2030 Globally, as KYC Identified as the Next Major Opportunity GlobeNewswire August 04, 2025 HAMPSHIRE, United Kingdom, Aug. 04, 2025 (GLOBE NEWSWIRE) — A new study from Juniper Research, the foremost experts in telecommunications and connectivity markets, has found operator revenue from network Application Programming Interfaces (APIs)
Certara Simcyp(R) Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling GlobeNewswire August 04, 2025 RADNOR, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) — Certara, Inc., a global leader in biosimulation, today announced that the European Medicines Agency (EMA) has formally qualified the Simcyp(R) Simulator for use in regulatory submissions
Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) announced that its global, multicenter, randomized Phase II registrational trial (COMPASSION-36/AK104-225) has been approved to initiate by both China's National Medical Products Administration (NMPA) and the U.S. Food and Drug Administration (FDA). The trial will evaluate cadonilimab, Akeso's first-in-class PD-1/CTLA-4 bispecific antibody, in combination with lenvatinib versus lenvatinib
The "Waste-to-Value, Industry Upgrade, and GBA Co-Creation" Technology Forum (the "Forum"), jointly organized by the GBA Economic and Trade Association, GBA Institute, All-China Environment Federation, and "The Hong Kong University of Science and Technology (HKUST) – Abs-lute Pure EnviroSci Limited (APEL) Joint Laboratory on Health and Environmental Innovation" under APEL, was successfully convened on 29
Harbour City, Hong Kong's most iconic shopping mall and tourist destination, has partnered withSanrio Hong Kong this Summer to host the “My Melodyã”Kiki & Lala 50th Anniversary Celebration – Summer Matsuri @ Harbour City”.From 29 July to 7 September 2025, the mall transforms into a whimsical Japanese summer matsuri, offering a vibrant mix of visual
TransEleven Claims Managers is pleased to announce that Chief Executive Officer, Shelle Hobbs, has been nominated for two Women in Insurance Awards (UK). TransEleven Claims Managers is pleased to announce that Chief Executive Officer Shelle Hobbs, has been nominated for two Women in Insurance Awards. Shelle has been nominated as Claims Professional of the Year
Sohu.com Limited (NASDAQ: SOHU) (“Sohu” or the “Company”),a leading Chinese online media platform and game business group, today reported unaudited financial results for the secondquarter ended June 30, 2025. https://mma.prnewswire.com/media/74524/sohu_com_logo.jpg SecondQuarter Highlights — Total revenues were US$126 million, down 27% year-over-year and 7% quarter-over-quarter. — Marketing services revenues were US$16million, down 21% year-over-year and up